A detailed history of Wedge Capital Management L L P transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Wedge Capital Management L L P holds 119,447 shares of PCRX stock, worth $2.05 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
119,447
Previous 51,500 131.94%
Holding current value
$2.05 Million
Previous $1.47 Million 22.06%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$11.7 - $28.46 $794,979 - $1.93 Million
67,947 Added 131.94%
119,447 $1.8 Million
Q2 2024

Jul 17, 2024

SELL
$25.5 - $31.51 $124,516 - $153,863
-4,883 Reduced 8.66%
51,500 $1.47 Million
Q1 2024

Apr 23, 2024

BUY
$27.7 - $35.48 $691,641 - $885,900
24,969 Added 79.48%
56,383 $1.65 Million
Q4 2023

Feb 01, 2024

BUY
$26.32 - $34.31 $826,816 - $1.08 Million
31,414 New
31,414 $1.06 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $787M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Wedge Capital Management L L P Portfolio

Follow Wedge Capital Management L L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.